0001127602-18-035752.txt : 20181210
0001127602-18-035752.hdr.sgml : 20181210
20181210204631
ACCESSION NUMBER: 0001127602-18-035752
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181206
FILED AS OF DATE: 20181210
DATE AS OF CHANGE: 20181210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacks Tyler
CENTRAL INDEX KEY: 0001464237
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37702
FILM NUMBER: 181227607
MAIL ADDRESS:
STREET 1: 77 MASSACHUSETTS AVENUE E17-517
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-12-06
0000318154
AMGEN INC
AMGN
0001464237
Jacks Tyler
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
Common Stock
2018-12-06
4
M
0
20000
82.60
A
28979
D
Common Stock
2018-12-06
4
S
0
20000
195.4116
D
8979
D
Nqso (Right to Buy)
82.60
2018-12-06
4
M
0
20000
0
D
2013-07-31
2022-07-31
Common Stock
20000
0
D
The price reported is an average price. the prices ranged from $195.28 to $195.83 per share for this cashless exercise of 20,000 stock options expiring July 31, 2022. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
These shares include 467 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
/s/ Tyler Jacks
2018-12-06